Emory University School of Medicine
Head and Neck Medical Oncology
Dr. Saba’s work is focused on the study and development of novel therapeutic agents and modalities in head and neck and esophageal cancer. He leads several clinical trials including national as well as investigator initiated studies focusing on novel approaches for treating these diseases.
Dr. Saba is a member of the National Cancer Institute's task force for recurrent metastatic head and neck cancer, and in 2016 was named co-chair of the Rare Tumors Task Force of the National Cancer Institute's Head and Neck Cancer Steering Committee. Prior to joining the faculty at Emory University, he was recognized for his outstanding contribution to the fellowship program at the University of Minnesotta. Dr. Saba is also an active member of the NRG Head and Neck Cancer steering Committee and serves on the American College of Radiology appropriateness criteria panel for head and neck cancer.
Dr. Saba earned his Medical Degree from the American University of Beirut Medical School. He completed a Residency in Internal Medicine at Tufts University School of Medicine in Boston, and Clinical Fellowships in Hematology and Oncology at Brown University School of Medicine, and in Bone Marrow Transplant at the University of Toronto Princess Margaret Hospital in Toronto, Canada.
Dr. Saba's research is focused on clinical and translational work in head and neck, and esophageal cancer. He has been the recipient of several NIH and industry funded grant support to study these malignancies. He has recently received funding from the NIH to examine novel genomic approaches for diagnosing HPV positive oropharyngeal cancers. He conducts and leads a number of head and neck cancer clinical trials with a focus on biomarker endpoints.
Among Dr Saba's contributions is serving as a co-leader of project 4 of the Emory Head and Neck Cancer SPORE involving the application of nano-therapeutics-based therapy for treating advanced head and neck cancer and serving as an investigator on the Department of Defense, USAMRMC grant looking at "Multi-Biomarker System Using Quantum Dot Technology for Assessments of Prognosis of NSCLC".
Dr. Saba has authored more than 100 multiple peer-reviewed articles, editorials, review papers, book chapters as well as two Uptodate chapters. He is a member of the editorial board of Cancer, Oral Oncology, Head Neck, American Journal of Clinical Oncology and Cancers of the Head and Neck.
View Publications on Research Gate
View publications on PubMed